2. Academic Validation
  3. N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase

N-hydroxyurea and hydroxamic acid inhibitors of cyclooxygenase and 5-lipoxygenase

  • Bioorg Med Chem Lett. 1999 Apr 5;9(7):979-84. doi: 10.1016/s0960-894x(99)00117-1.
P J Connolly 1,  S K Wetter,  K N Beers,  S C Hamel,  R H Chen,  M P Wachter,  J Ansell,  M M Singer,  M Steber,  D M Ritchie,  D C Argentieri
Affiliations

Affiliation

  • 1 The R.W. Johnson Pharmaceutical Research Institute, Raritan, NJ 08869, USA.
PMID: 10230624 DOI: 10.1016/s0960-894x(99)00117-1
Abstract

Two series of compounds (1 and 2) having structural features of the dual COX/5-LO inhibitor tepoxalin and the 5-LO inhibitor ABT-761 were prepared. Many of these hybrid compounds are potent COX and 5-LO inhibitors; two compounds (1a and 2t) inhibit eicosanoid biosynthesis in an ex vivo assay.

Figures
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z